AbbVie and Gedeon Richter Plc. ('Richter') today announced a new discovery, co-development and license agreement to advance novel targets for the potential treatment of neuropsychiatric conditions.

Anxiety and depression are more common among people with Crohn’s disease, and they can worsen symptoms. Here’s why and ways ...

Highmark Health today announced initial results of Mental Well-Being powered by Spring Health, delivering significant ...

The Boston-based startup is developing what executives hope will be more effective treatments for depression, anxiety, and ...

Prescription digital therapeutics for mental health have the potential to increase patient access to care, but major barriers ...

ADHD is a behavioral disorder that affects attention, causes hyperactivity, and leads to impulsive actions. Anxiety is a ...

In recent years, ketamine has emerged as a groundbreaking treatment option for various mental health conditions, particularly depression, anxiety, PTSD, and chronic pain disorders.

Elite Psychology Group is setting a new standard in anxiety therapy, offering innovative and comprehensive solutions to individuals struggling with anxiety-related disorders.

Psychiatric treatments focused on managing depression, generalized anxiety, sleep disturbances, and suicidal thoughts ...

She is board certified in general and child/adolescent psychiatry and specializes in the treatment of conditions ... the triggers that produce the anxiety. While generalized anxiety disorder ...